Market Overview:
The global stem cell reconstructive market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising incidence of chronic diseases, increasing demand for regenerative therapies, and technological advancements in stem cell therapy. The embryonic stem cell segment is expected to account for the largest share of the global stem cell reconstructive market in 2018. This can be attributed to the high potential of embryonic stem cells in regenerative therapies and their ability to differentiate into all types of cells in the body. However, adult stem cells are gaining popularity due their ability to self-renew and generate differentiated cells that are specific for a particular tissue or organ, without any ethical concerns associated with embryonic stem cells. Hospitals are expected to account for the largest share of the globalstemcell reconstructive marketin2018.
Product Definition:
A stem cell is a cell in the body that can renew itself and differentiate into other types of cells. The term “stem cell” has been used to describe embryonic cells, adult tissue cells, and umbilical cord blood cells. Reconstructive surgery refers to the restoration of form and function to a part of the body that has been damaged by injury or disease. Stem cell reconstructive surgery uses stem cells to regenerate new tissue in an injured or diseased area.
Embryonic Stem Cell:
Embryonic stem cells (ESCs) are the pluripotent cells that can differentiate into all germ layers during development. These are currently being studied as a potential source for cell replacement therapies to treat failed organs and tissues. Currently, research is focused on understanding the basic biology of these cells and their therapeutic potential in regenerative medicine, with an emphasis on applications in cardiovascular disease treatment and organ repair.
Adult Stem Cell:
Adult stem cells are also known as post-mitotic cells. These are found in the bone marrow, peripheral blood, dental pulp, skin and other organs. They have the ability to repair and regenerate tissues in adults as well as throughout life span.
Application Insights:
Based on application, the global market is segmented into hospitals, research institutes and other centers. Hospitals held the largest share in 2017 owing to increasing number of stem cell transplant surgeries performed there. Moreover, growing government support towards building new hospitals that can perform these types of life-saving procedures is also contributing to segment growth.
Research Institutes are anticipated to be fastest-growing application over the forecast period due to increase in R&D activities pertaining to adult and embryonic stem cells being conducted at various institutions across the world. Growing number of clinical trials being performed at these institutes for testing different types of stromal cells derived from adipose tissue as well as umbilical cord blood is also expected fuel market growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of research institutes and companies engaged in stem cell research is one of the major factors contributing to its dominance. Moreover, increasing government funding for such projects is also expected to drive growth over the forecast period. For instance, according to an article published by Stem Cell Research & Therapy in 2016, U.S.-based institutions received around USD X million from federal agencies for stem cell-related projects between 2011 and 2015; this represents a significant proportion of overall funding received by these institutes during that period (p 7).
Asia Pacific region is anticipated to grow at a lucrative rate over the forecast period owing to rising awareness about various advanced therapies among patients as well as healthcare professionals coupled with growing investment by private players in this region.
Growth Factors:
- Increasing incidence of chronic diseases: The increasing incidence of chronic diseases such as cancer, heart disease, and diabetes is expected to drive the demand for stem cell reconstructive therapies.
- Growing awareness about stem cell therapies: There is a growing awareness about the potential benefits of stem cell therapies among patients and healthcare professionals. This is likely to boost the demand for these treatments in the coming years.
- Technological advancements in stem cell therapy: The technological advancements in stem cell therapy are helping to improve the efficacy and safety of these treatments. This is likely to propel the growth of this market in the near future.
- Rising number of clinical trials: There has been a significant increase in clinical trials involving stem cells over the past few years, owing to their potential therapeutic benefits. This is expected to drive market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Reconstructive Market Research Report
By Type
Embryonic Stem Cell, Adult Stem Cell
By Application
Hospitals, Research Institutes, Others
By Companies
Osiris Therapeutics, NuVasive, Cytori Therapeutics, Takeda (TiGenix), Cynata, Celyad, Medi-post, Anterogen, Molmed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Reconstructive Market Report Segments:
The global Stem Cell Reconstructive market is segmented on the basis of:
Types
Embryonic Stem Cell, Adult Stem Cell
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Osiris Therapeutics
- NuVasive
- Cytori Therapeutics
- Takeda (TiGenix)
- Cynata
- Celyad
- Medi-post
- Anterogen
- Molmed
Highlights of The Stem Cell Reconstructive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Embryonic Stem Cell
- Adult Stem Cell
- By Application:
- Hospitals
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Reconstructive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell reconstructive surgery is a surgical procedure that uses stem cells to help restore damaged or missing tissue in the body.
Some of the major players in the stem cell reconstructive market are Osiris Therapeutics, NuVasive, Cytori Therapeutics, Takeda (TiGenix), Cynata, Celyad, Medi-post, Anterogen, Molmed.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Reconstructive Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Reconstructive Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Reconstructive Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Reconstructive Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Reconstructive Market Size & Forecast, 2018-2028
4.5.1 Stem Cell Reconstructive Market Size and Y-o-Y Growth
4.5.2 Stem Cell Reconstructive Market Absolute $ Opportunity
Chapter 5 Global Stem Cell Reconstructive Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell Reconstructive Market Size Forecast by Type
5.2.1 Embryonic Stem Cell
5.2.2 Adult Stem Cell
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell Reconstructive Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Stem Cell Reconstructive Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Research Institutes
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Reconstructive Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Reconstructive Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Stem Cell Reconstructive Analysis and Forecast
9.1 Introduction
9.2 North America Stem Cell Reconstructive Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Stem Cell Reconstructive Market Size Forecast by Type
9.6.1 Embryonic Stem Cell
9.6.2 Adult Stem Cell
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Stem Cell Reconstructive Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Research Institutes
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Stem Cell Reconstructive Analysis and Forecast
10.1 Introduction
10.2 Europe Stem Cell Reconstructive Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Stem Cell Reconstructive Market Size Forecast by Type
10.6.1 Embryonic Stem Cell
10.6.2 Adult Stem Cell
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Stem Cell Reconstructive Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Research Institutes
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Stem Cell Reconstructive Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Stem Cell Reconstructive Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Stem Cell Reconstructive Market Size Forecast by Type
11.6.1 Embryonic Stem Cell
11.6.2 Adult Stem Cell
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Stem Cell Reconstructive Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Research Institutes
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Stem Cell Reconstructive Analysis and Forecast
12.1 Introduction
12.2 Latin America Stem Cell Reconstructive Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Stem Cell Reconstructive Market Size Forecast by Type
12.6.1 Embryonic Stem Cell
12.6.2 Adult Stem Cell
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Stem Cell Reconstructive Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Research Institutes
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Stem Cell Reconstructive Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Stem Cell Reconstructive Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Stem Cell Reconstructive Market Size Forecast by Type
13.6.1 Embryonic Stem Cell
13.6.2 Adult Stem Cell
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Stem Cell Reconstructive Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Research Institutes
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Reconstructive Market: Competitive Dashboard
14.2 Global Stem Cell Reconstructive Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Osiris Therapeutics
14.3.2 NuVasive
14.3.3 Cytori Therapeutics
14.3.4 Takeda (TiGenix)
14.3.5 Cynata
14.3.6 Celyad
14.3.7 Medi-post
14.3.8 Anterogen
14.3.9 Molmed
